Ignota labs

Seed Biotech

Ignota Labs utilises the latest deep learning approaches to identify the mechanism of toxicity, predict its effects on the human body, and balance that with therapeutic effectiveness.

About

Ignota Labs is an AI-driven drug rescue company that identifies, acquires, and reformulates late-stage drug candidates that have failed due to toxicity issues. Their platform combines proprietary mitochondrial DNA data and machine learning to systematically diagnose the root causes of toxicity and engineer safer, clinically viable reformulations.

Milestones

  • Founded 2021
  • Invested 2025

Leadership

  • Sam Windsor
  • Jordan Lane
  • Layla Hosseini-Gerami

Links

“LQD have always been generous with their time and connections, something that is so important as an early stage company. Including introducing us to our latest lead investor. I see Santiago as a trusted partner who can help ensure that we are building towards the right milestones to ensure we get to the next cash milestones – a critical goal for DeepTech companies!”

Sam Windsor Founder

Ignota Labs at a glance.

Ignota Labs Raises USD $6.9M Seed Funding to Turn Around Failed Drugs.

February 26, 2025

Read more

Dr Layla Hosseini-Gerami Named as One of Innovate UK’s Trailblazing Women Innovators to Watch in 2025.

February 4, 2025

UK's trailblazing women to watch in 2025

Ignota Labs Publishes Research on SAFEPATH Platform for Drug Toxicity Analysis.

October, 2024

Read more

Next company